|0.0||Treat as an outpatient|
30-day death rate = 0.7%
|1.0||Treat as an outpatient|
30-day death rate = 3.2%
|2.0||Consider a short stay in hospital|
30-day death rate = 13.0%
|3.0||Consider a short stay in hospital|
30-day death rate = 17.0%
30-day death rate = 41.5%
30-day death rate = 57.0%
W Lim, M M van der Eerden, R Laing, W Boersma, N Karalus, G Town, S Lewis, and J Macfarlane. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May; 58(5): 377–382. doi: 10.1136/thorax.58.5.377.
Shah BA, et. al. Validity of Pneumonia Severity Index and CURB-65 Severity Scoring Systems in Community Acquired Pneumonia in an Indian Setting. The Indian Journal of Chest Diseases & Allied Sciences. 2010;Vol.52.
Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am. J. Med. 2005;118(4): 384–92.doi:10.1016/j.amjmed.2005.01.006. PMID 15808136
Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing. 2006;35(3):286-91.
Capelastegui A, España PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27(1):151-7.